会员体验
专利管家(专利管理)
工作空间(专利管理)
风险监控(情报监控)
数据分析(专利分析)
侵权分析(诉讼无效)
联系我们
交流群
官方交流:
QQ群: 891211   
微信请扫码    >>>
现在联系顾问~
热词
    • 1. 发明申请
    • MODULATORS OF PHOSPHOINOSITIDE 3-KINASE
    • 磷酸肌醇3-激酶调节剂
    • WO2003035618A2
    • 2003-05-01
    • PCT/US2002/034086
    • 2002-10-24
    • ICONIX PHARMACEUTICALS, INC.MELESE, TeriPERKINS, Edward, L.NGUYEN, Allen, T., Q.SUN, Dongxu
    • MELESE, TeriPERKINS, Edward, L.NGUYEN, Allen, T., Q.SUN, Dongxu
    • C07D
    • C07D215/22C07D215/38C07D401/12
    • Compounds of Formula (I) are effective modulators of PI3 kinase wherein R 1 is H, hydroxy, amino, lower alkyl, or trihalomethyl; R 2 is amino, lower alkylamino, lower acylamino, arylamino, arylacyl-amino, heteroaryl-amino, heteroaryl-acyl amino, where aryl and heteroaryl are substituted with 0-3 substituents selected from the group consisting of halo, trihalomethyl, hydroxy, lower alkyl and lower alkoxy, or a substituent of the form -(CH 2 ) n -C(=X)-R 8 , where n is 0-3 inclusive and X is O or NR 9 , where R 9 is H, lower alkyl, or R 1 and R 2 together form -CH=N-X- where X is CH, NH, O, or S, and R 8 is H, lower alkyl, lower alkoxy, aryl, aralkyl, or -(CH 2 ) m CR 10 R 11 R 12 , where m is 0-3 inclusive, and R 10 , R 11 , and R 12 are each independently H, lower alkyl, aryl, aralkyl, hydroxy, lower alkoxy, aryloxy, aralkoxy, amino, lower alkylamino, arylamino, aralkylamino, heteroaryl amino, or heteroaralkyl amino, where aryl and heteroaryl are substituted with 0-3 substituents selected from the group consisting of halo, hydroxy, and lower alkyl; R 3 is H or lower alkyl; and R 4 , R 5 , R 6 , R 7 are each independently H, halo, hydroxy, amino, nitro, lower alkyl, or lower alkoxy; and pharmaceutically acceptable salts thereof.
    • 式(I)化合物是PI3激酶的有效调节剂,其中R 1是H,羟基,氨基,低级烷基或三卤代甲基; R 2是氨基,低级烷基氨基,低级酰基氨基,芳基氨基,芳基酰基氨基,杂芳基 - 氨基,杂芳基 - 酰基氨基,其中芳基和杂芳基被0-3个取代基取代,所述取代基选自 卤素,三卤代甲基,羟基,低级烷基和低级烷氧基,或 - (CH 2)n -C(= X)-R 8形式的取代基 其中n为0-3(包括0和3),X为O或NR 9,其中R 9为H,低级烷基或R 1, 其中X为CH,NH,O或S,并且R 8为H,低级烷基,低级烷氧基 ,芳基,芳烷基或 - (CH 2)m CR 12 R 11 R 12, 其中m为0-3(包括0和3),并且R 10,R 11和R 12各自独立地为H,低级烷基 ,芳基,芳烷基,羟基,低级烷氧基,芳氧基,芳烷氧基,氨基,低级烷基氨基,芳基氨基,芳烷基氨基,杂芳基氨基或杂芳烷基氨基,其中芳基和杂芳基是取代的 用选自卤素,羟基和低级烷基的0-3个取代基取代; R 3是H或低级烷基; 和R 4,R 5,R 6,R 7各自独立地为H,卤素,羟基,氨基 ,硝基,低级烷基或低级烷氧基; 及其药学上可接受的盐。
    • 2. 发明申请
    • MODULATORS OF PHOSPHOINOSITIDE 3-KINASE
    • 磷酸三辛酯3激酶的调节剂
    • WO2003034997A2
    • 2003-05-01
    • PCT/US2002/034054
    • 2002-10-24
    • ICONIX PHARMACEUTICALS, INC.MELESE, TeriPERKINS, Edward, L.NGUYEN, Allen, T., Q.SUN, Dongxu
    • MELESE, TeriPERKINS, Edward, L.NGUYEN, Allen, T., Q.SUN, Dongxu
    • A61K
    • C07D495/14
    • Compounds of formula 1 are effective modulators of P13 kinase: wherein X is CR 9, R 10 , 0, NR 11 (where R 9 and R 1O are each independently H, lower alkyl, lower alkoxy, or halo, and R 11 is H or lower alkyl); or single bond; R 1 is H, lower alkyl, aryl, aralkyl; R 2 is H, lower alkyl, aryl, aralkyl, heteroaryl, heteroaryl-alkyl, lower alkoxy, amino, lower alkylamino, lower acylamino, arylamino, arylacyl-amino, heteroaryl-amino, heteroaryl-acyl amino, thio, lower alkylthio, arylthio, or aralkyl-thio, where aryl and heteroaryl are substituted with 0-3 substituents selected from the group consisting of halo, trihalomethyl, hydroxy, lower alkyl and lower alkoxy; R 3 , R 4 , R 5 , R 6 , R 7 and R 8 are each independently H, lower alkyl, lower alkoxy, or halo; or a pharmaceutically acceptable salt or ester thereof.
    • 式1的化合物是P13激酶的有效调节剂:其中X是CR 9,R 11,R 11,其中R sb R 9和R 11各自独立地为H,低级烷基,低级烷氧基或卤素,R 11为H或低级烷基)。 或单键; R 1是H,低级烷基,芳基,芳烷基; R 2是H,低级烷基,芳基,芳烷基,杂芳基,杂芳基 - 烷基,低级烷氧基,氨基,低级烷基氨基,低级酰基氨基,芳基氨基,芳酰基 - 氨基,杂芳基 - 氨基,杂芳基 - 酰基氨基 其中芳基和杂芳基被0-3个选自卤素,三卤代甲基,羟基,低级烷基和低级烷氧基的取代基所取代; R 3,R 4,R 4,R 6,R 7,R 7和R 7,和 R 8各自独立地为H,低级烷基,低级烷氧基或卤素; 或其药学上可接受的盐或酯。
    • 5. 发明申请
    • PARB INHIBITORS
    • PARB抑制剂
    • WO0244157A3
    • 2002-12-27
    • PCT/US0146811
    • 2001-12-03
    • ICONIX PHARM INCMELESE TERIPERKINS EDWARD LYEH ELAINESUN DONXU
    • MELESE TERIPERKINS EDWARD LYEH ELAINESUN DONXU
    • A61P35/00C07D237/32A61K31/50C07D217/24C07D239/90C07D279/08C07D401/06C07D401/12C07D409/04
    • C07D237/32
    • Compounds of formula 1, 2, and 3 where A1 is C(R4)or N; A2 is C(R5) or S; R1 is H, lower alkyl, halo, or a carbonyl; R2 is H, lower alkyl, acyl, or forms a double bond with an adjacent ring atom; R3 is H, lower alkyl, halo, aryl, aralkyl, acyl, lower alkenyl, or a radical or the form (CH2)nC(O)-Ra, where Ra is lower alkyl, OH, NH2, lower alkoxy, lower aklylamino, di(lower alkyl)amino, aryl, or heterocyclyl, or forms a double bond with an adjacent ring atom; R4 is H, lower alkyl, or forms a double bond with an adjacent ring atom, R5 is H, lower alkyl, OH, halo, lower alkoxy, lower alkyl-thio, aryl-thio, or heterocyclyl-thio; R6 and R7 are each independently H, lower alkyl, OH, lower alkoxy, halo, nitro, amino, thio, acyl, lower alkylamino, acyloxy, acylamino, sulfinyl, sulfonyl, alkylsulfinyl, alkylsulfonyl, arylsulfonyl, aryl, heterocyclyl, aralkyl, or heterocyclyl-alkyl; R10 is H, lower alkyl, lower alkenyl, aryl, heterocyclyl, aryl-lower alkyl, or heterocyclyl-lower alkyl; and R11, R12, and R13 are each independently halo, nitro, OH, NH2, or lower alkyl, and pharmaceutically acceptable salts thereof, are effective modulators of PARP enzymes.
    • 式1,式2和式3的化合物,其中A1是C(R4)或N; A2是C(R5)或S; R1是H,低级烷基,卤素或羰基; R2是H,低级烷基,酰基或与相邻的环原子形成双键; R3是H,低级烷基,卤素,芳基,芳烷基,酰基,低级链烯基或基团或形式(CH2)nC(O)-Ra,其中Ra是低级烷基,OH,NH2,低级烷氧基,低级烷基氨基, 二(低级烷基)氨基,芳基或杂环基,或与相邻的环原子形成双键; R4是H,低级烷基或与相邻的环原子形成双键,R5是H,低级烷基,OH,卤素,低级烷氧基,低级烷基 - 硫基,芳基 - 硫基或杂环基 - 低级烷基,OH,低级烷氧基,卤素,硝基,氨基,硫代,酰基,低级烷基氨基,酰氧基,酰基氨基,亚磺酰基,磺酰基,烷基亚磺酰基,烷基磺酰基,芳基磺酰基,芳基,杂环基,芳烷基或 杂环基 - 烷基; R10为H,低级烷基,低级链烯基,芳基,杂环基,芳基 - 低级烷基或杂环基 - 低级烷基; 和R 11,R 12和R 13各自独立地为卤素,硝基,OH,NH 2或低级烷基,及其药学上可接受的盐是PARP酶的有效调节剂。